metricas
covid
Medicina Clínica (English Edition) Chronic use of renin–angiotensin–aldosterone inhibitors in hypertensive COVI...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Chronic use of renin–angiotensin–aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis
Uso crónico de los inhibidores del sistema renina-angiotensina-aldosterona en pacientes con COVID-19 e hipertensión arterial: Resultados de un registro español y metaanálisis
Álvaro Aparisia,
Corresponding author
alvaro_aparisi@hotmail.com

Corresponding author.
, Pablo Cataláa, Ignacio J. Amat-Santosa,b, Marta Marcos-Mangasa, Diego López-Oterob,c, Carlos Verasa, Javier López-Paisb,c, Gonzalo Cabezón-Villalbaa, Carla Eugenia Cacho Antonioc, Jordi Candelaa, Pablo Antúnez-Muiñosc, José Francisco Gila, Teba González Ferreroc, Gino Rojasa, Marta Pérez-Pozac, Aitor Uribarria,b, Oscar Otero-Garcíac, Pablo Elpidio García-Granjaa,b, Víctor Jiménez Ramosc, Ana Revillaa,b..., Carlos Dueñasd, Itzíar Gómeza,b, José Ramón González-Juanateyb,c, J. Alberto San Romána,bVer más
a Servicio de Cardiología, Hospital Clínico Universitario, Valladolid, Spain
b Centro de Investigación Biomédica en Red – Cardiovascular (CIBERCV), Spain
c Servicio de Cardiología, Hospital Clínico Universitario, Santiago de Compostela, Spain
d Servicio de Enfermedades Infecciosas, Hospital Clínico Universitario, Valladolid, Spain
Read
167
Times
was read the article
2
Total PDF
165
Total HTML
Share statistics
Article information
ISSN: 23870206
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 10 5 0 5
2025 9 7 0 7
2025 8 11 0 11
2025 7 9 0 9
2025 6 4 0 4
2025 5 4 0 4
2025 4 6 0 6
2025 3 4 0 4
2025 2 2 0 2
2025 1 2 0 2
2024 12 6 0 6
2024 11 3 0 3
2024 10 3 0 3
2024 9 6 0 6
2024 8 10 0 10
2024 7 4 0 4
2024 6 2 0 2
2024 5 5 0 5
2024 4 3 0 3
2024 3 11 0 11
2024 2 1 0 1
2024 1 3 0 3
2023 12 8 0 8
2023 11 5 0 5
2023 10 2 0 2
2023 9 4 2 6
2023 8 3 0 3
2023 7 1 0 1
2023 6 3 0 3
2023 4 2 0 2
2023 3 1 0 1
2023 2 1 0 1
2023 1 2 0 2
2022 12 1 0 1
2022 11 1 0 1
2022 10 2 0 2
2022 9 2 0 2
2022 8 3 0 3
2022 7 4 0 4
2022 6 5 0 5
2022 5 4 0 4
Show all

Follow this link to access the full text of the article